• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close

Blog

In partnership with STAT News, Truveta Research explored trends in the incidence of testing and diagnosis of PVD/PAD among U.S. patients aged 50 years and older from 2018 to 2024.

Trends in testing and diagnosis of peripheral vascular disease in the US

July 25, 2024
Truveta Research explores prescribing and dispensing trends for GLP-1 medications labeled for type 2 diabetes and obesity from January 2018 through June 2024.

GLP-1 RA prescription trends: January 2018 – June 2024

July 23, 2024
Truveta Symposium brings together healthcare, public health, and life science organizations with a shared mission of Saving Lives with Data

Truveta Symposium brings together healthcare, public health, and life science organizations with a shared mission of Saving Lives with Data

July 9, 2024

Zepbound outperforms Ozempic and Wegovy in head-to-head weight loss study

July 8, 2024

Mounjaro bests Ozempic for weight loss in first head-to-head comparison of real-world use

July 8, 2024

Ozempic v. Mounjaro? There’s a clear winner for weight loss, study finds

July 8, 2024

Mounjaro leads to significantly more weight loss than Ozempic, study suggests

July 8, 2024
In the largest comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data – now published in JAMA Internal Medicine – Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15% weight loss than those taking semaglutide.

Real-world data study comparing Mounjaro and Ozempic for weight loss published in JAMA Internal Medicine

July 8, 2024
  • « Previous
  • 1
  • …
  • 22
  • 23
  • 24
  • …
  • 41
  • Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.